Publication: Ascorbic acid: a promising agent in chronic kidney disease?
Files
Program
KU-Authors
KU Authors
Co-Authors
Afşar, Barış
Editor & Affiliation
Compiler & Affiliation
Translator
Other Contributor
Date
Language
Type
Embargo Status
NO
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
Asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, is related with impaired endothelial function and poor outcomes in chronic kidney disease (CKD) patients. In addition, oxidative stress and inflammation are also a common problemin CKD patients, and both have an important role in the development and progression of atherosclerosis and increased cardiovascular events in CKD. Ascorbic acid might be a promising agent in CKD for improving outcome by decreasing oxidative stress and ADMA levels.
Source
Publisher
Oxford University Press (OUP)
Subject
Urology and nephrology
Citation
Has Part
Source
Clinical Kidney Journal
Book Series Title
Edition
DOI
10.1093/ckj/sfy044